Yamamoto, A.; Wada, H.; Ichikawa, Y.; Mizuno, H.; Tomida, M.; Masuda, J.; Makino, K.; Kodama, S.; Yoshida, M.; Fukui, S.;
et al. Evaluation of Biomarkers of Severity in Patients with COVID-19 Infection. J. Clin. Med. 2021, 10, 3775.
https://doi.org/10.3390/jcm10173775
AMA Style
Yamamoto A, Wada H, Ichikawa Y, Mizuno H, Tomida M, Masuda J, Makino K, Kodama S, Yoshida M, Fukui S,
et al. Evaluation of Biomarkers of Severity in Patients with COVID-19 Infection. Journal of Clinical Medicine. 2021; 10(17):3775.
https://doi.org/10.3390/jcm10173775
Chicago/Turabian Style
Yamamoto, Akitaka, Hideo Wada, Yuhuko Ichikawa, Hikaru Mizuno, Masaki Tomida, Jun Masuda, Katsutoshi Makino, Shuji Kodama, Masamichi Yoshida, Shunsuke Fukui,
and et al. 2021. "Evaluation of Biomarkers of Severity in Patients with COVID-19 Infection" Journal of Clinical Medicine 10, no. 17: 3775.
https://doi.org/10.3390/jcm10173775
APA Style
Yamamoto, A., Wada, H., Ichikawa, Y., Mizuno, H., Tomida, M., Masuda, J., Makino, K., Kodama, S., Yoshida, M., Fukui, S., Moritani, I., Inoue, H., Shiraki, K., & Shimpo, H.
(2021). Evaluation of Biomarkers of Severity in Patients with COVID-19 Infection. Journal of Clinical Medicine, 10(17), 3775.
https://doi.org/10.3390/jcm10173775